Breaking Meta Reaches Up To $18 Billion Settlement Over Lawsuit Alleging Addictive Platform Design Affecting Children NFL Confirms Ineligibility for Players Returning to College Eight Dead in Billings Home Fire, Authorities Investigate as Homicide Dolly Parton’s Life and Career Featured in Visual Retrospective LIV Golf Announces Staff Reductions Amidst Shift from Saudi Funding

Wednesday August 26, 2026

Reporter

Nektar Therapeutics

4Articles Published

5Communities Covered

Published Articles

Press Release

Nektar Announces Publication in The Lancet of Positive Phase 2b REZOLVE-AD 16-Week Induction Results of Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis

Aug 25

Press Release

Nektar Therapeutics Announces Second Quarter 2026 Financial Results

Aug 13

Press Release

Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets

Jul 28

Press Release

Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jul 24